Oncolytics Biotech Inc., of Calgary, Alberta, received U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was issued U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, received U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was awarded U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent 6,649,157 titled "Viruses for the Treatment of Cellular Proliferative Disorders," covering the treatment of Ras-mediated tumors using modified herpes viruses

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No